Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Germany's Merck sees long-term growth in cancer drug Erbitux
Germany's Merck sees long-term growth in cancer drug Erbitux
Germany's Merck sees long-term growth in cancer drug Erbitux
Submitted by
admin
on October 4, 2013 - 10:27am
Source:
Yahoo/Reuters
News Tags:
Erbitux
Merck KGaA
Avastin
colorectal cancer
Headline:
Germany's Merck sees long-term growth in cancer drug Erbitux
Do Not Allow Advertisers to Use My Personal information
